Joan M. Carboni
Bristol-Myers Squibb (United States)(US)Bristol-Myers Squibb (Sweden)(SE)
Publications by Year
Research Areas
Growth Hormone and Insulin-like Growth Factors, Metabolism, Diabetes, and Cancer, Cancer, Hypoxia, and Metabolism, HER2/EGFR in Cancer Research, Estrogen and related hormone effects
Most-Cited Works
- → Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival(2008)405 cited
- → Eleutherobin, a New Cytotoxin that Mimics Paclitaxel (Taxol) by Stabilizing Microtubules(1997)294 cited
- → Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 Diabetes(2010)284 cited
- → BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR(2009)278 cited
- → Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-κB and Snail(2007)247 cited
- Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol).(1998)
- →